Pro- and anti-inflammatory mediators

Pro- and anti-inflammatory mediators represent a broad and heterogeneous class of endogenous signaling molecules, primarily cytokines, chemokines, and lipid mediators, that orchestrate the body's immune response to stimuli such as infection, injury, or tissue damage (StatPearls, 2023). Pro-inflammatory mediators, including Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), are released by immune cells to initiate the inflammatory cascade, promote leukocyte recruitment, and activate systemic defense mechanisms (PubMed, 2022). Conversely, anti-inflammatory mediators such as Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-beta) function to limit the duration and intensity of these responses, facilitating tissue repair and preventing excessive damage (Nature Reviews Immunology, 2018). A persistent imbalance between these two groups, often characterized by an overproduction of pro-inflammatory factors or a deficiency in anti-inflammatory signaling, is a central driver in the pathogenesis of chronic inflammatory and autoimmune diseases (NIH, 2021). Therapeutic strategies in biotechnology frequently involve the use of monoclonal antibodies to neutralize specific pro-inflammatory cytokines or small molecules to inhibit their downstream signaling pathways, thereby restoring immunological homeostasis (Frontiers in Pharmacology, 2020).

Other names

Inflammatory mediatorsCytokines and chemokinesInflammatory signaling moleculesInflammatory markers

Neutralization of pro-inflammatory cytokines, inhibition of cyclooxygenase enzymes to reduce prostaglandin synthesis, or activation of anti-inflammatory signaling pathways.